Childress Capital Advisors’s Ingevity NGVT Stock Holding History

Childress Capital Advisors’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-29	Closed	-$2K	–	670
2020 Q4	$2K	Buy	+29	New	+$1.89K	﹤0.01%	977

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Childress Capital Advisors's NGVT Position: Q1 2021 in Review

Childress Capital Advisors sold out of Ingevity (NGVT) in Q1 2021, closing a stake of 29 shares — an estimated $2K sold.

Childress Capital Advisors first reported a position in NGVT in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 286 funds tracked by Wall St. Rank hold NGVT as of Q1 2021.

Childress Capital Advisors reported no remaining Ingevity position as of Q1 2021 after selling out during the quarter.
Childress Capital Advisors sold 29 Ingevity shares in Q1 2021, an estimated $2K.
Childress Capital Advisors first reported a position in Ingevity in Q4 2020 and held it in 1 quarter.
Childress Capital Advisors's Ingevity position peaked at $2K in Q4 2020.
286 funds tracked by Wall St. Rank held Ingevity as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.